首页> 外文期刊>International Medical Case Reports Journal >Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report
【24h】

Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report

机译:氯氮平与维持性电抽搐治疗相结合可大幅改善患有难治性精神分裂症的年轻患者:一例

获取原文
           

摘要

Objectives: Although clozapine is considered the only effective pharmacological option for patients with treatment-resistant schizophrenia (TRS), around 30–40% of patients show clozapine resistance. Modified electroconvulsive therapy augmentation is reportedly clinically effective for clozapine-resistant schizophrenia, but few case reports have described the efficacy of combining clozapine and continuous/maintenance ECT for patients with TRS. Methods: We present the case of a young patient with TRS who was treated using combination therapy with clozapine and maintenance ECT (m-ECT). Results: The patient achieved drastic improvement under combination therapy with clozapine and m-ECT. Total Positive and Negative Syndrome Scale (PANSS) score fell markedly by 36 (from 108 to 72) using the combination of clozapine and m-ECT. Behaviors not reflected directly by PANSS score also improved. For example, the problem of being unable to take oral drugs stably because of delusions of poisoning was resolved. Furthermore, the patient maintained improvement under m-ECT, and long-term homestays became possible. Conclusion: Combination therapy with clozapine and m-ECT proved greatly effective in this case. Further clinical trials of this combination therapy for TRS are needed to confirm the effectiveness. Further studies are also expected to examine effective periods for this therapy.
机译:目的:尽管氯氮平被认为是治疗难治性精神分裂症(TRS)患者的唯一有效药理学选择,但约30–40%的患者显示氯氮平耐药。据报道,改良的电抽搐治疗对氯氮平耐药的精神分裂症在临床上有效,但很少有病例报道描述了氯氮平与连续/维持ECT联合治疗TRS患者的疗效。方法:我们介绍了一位年轻的TRS患者,该患者接受氯氮平和维持性ECT(m-ECT)联合治疗。结果:在与氯氮平和m-ECT联合治疗的情况下,患者获得了明显的改善。使用氯氮平和m-ECT的综合阳性和阴性综合症状量表(PANSS)评分显着下降了36(从108降低到72)。 PANSS得分未直接反映的行为也得到了改善。例如,解决了由于中毒的幻想而不能稳定地服用口服药物的问题。此外,患者在m-ECT下保持了改善,并且可以长期寄宿。结论:氯氮平与m-ECT联合治疗在这种情况下非常有效。需要对TRS的这种联合疗法进行进一步的临床试验,以确认有效性。还期望进一步的研究来检查该疗法的有效期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号